In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
Consultant360 spoke with Amy Ushry, RN, MPH, who discussed rates of maternal morbidity and mortality and ongoing endeavors to reduce these rates at the NPWH 22nd Annual Premier Women’s Healthcare...
Consultant360 spoke with Amy Ushry, RN, MPH, who discussed rates of maternal morbidity and mortality and ongoing endeavors to reduce these rates at the NPWH 22nd Annual Premier Women’s Healthcare...
David G Schwartz, PhD, and Stephen Lankenau, PhD, answer our questions on the results of a study examining the effectiveness of equipping members of the community with naloxone and a smartphone application...
David G Schwartz, PhD, and Stephen Lankenau, PhD, answer our questions on the results of a study examining the effectiveness of equipping members of the community with naloxone and a smartphone application...
